Targeted therapy is a type of cancer treatment that uses drugs or other substances to specifically identify and attack cancer cells while causing minimal damage to normal cells. Unlike traditional chemotherapy, which can affect both cancerous and healthy cells, targeted therapy works by targeting specific molecules or pathways that are involved in the growth and survival of cancer cells.

When and why do people go for Targeted Therapy?

People undergo targeted therapy for various types of cancer, including breast cancer, lung cancer, colorectal cancer, and melanoma, among others. Targeted therapy may be recommended when genetic mutations or specific biomarkers are present in the cancer cells that make them susceptible to targeted treatment. Additionally, targeted therapy may be used as a first-line treatment or in combination with other treatments such as chemotherapy, radiation therapy, or immunotherapy to improve outcomes or reduce side effects.

What makes Targeted Therapy different from other treatment options?

Targeted therapy offers a more precise and tailored approach to cancer treatment compared to other options. While traditional treatments like chemotherapy and radiation therapy affect all rapidly dividing cells, targeted therapy specifically targets cancer cells based on their unique molecular characteristics. This can lead to more effective and less toxic treatments with fewer side effects compared to traditional therapies. Additionally, targeted therapy may be effective for cancers that are resistant to other treatments or have limited treatment options available.

How does life change after Targeted Therapy?

Life after targeted therapy can vary depending on the type of cancer, stage of treatment, and individual response to therapy. For some individuals, targeted therapy may result in long-term remission or stabilization of the disease, allowing them to resume normal activities and enjoy a better quality of life. However, for others, targeted therapy may be a part of ongoing treatment to manage cancer as a chronic condition. Overall, targeted therapy offers hope for improved outcomes and a better quality of life for many cancer patients, with ongoing research and advancements expanding its potential benefits.